1. Home
  2. TDW vs ACAD Comparison

TDW vs ACAD Comparison

Compare TDW & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tidewater Inc.

TDW

Tidewater Inc.

HOLD

Current Price

$85.74

Market Cap

4.3B

ML Signal

HOLD

Logo ACADIA Pharmaceuticals Inc.

ACAD

ACADIA Pharmaceuticals Inc.

HOLD

Current Price

$20.59

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TDW
ACAD
Founded
1956
1993
Country
United States
United States
Employees
7300
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
3.8B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
TDW
ACAD
Price
$85.74
$20.59
Analyst Decision
Hold
Buy
Analyst Count
4
22
Target Price
$81.33
$30.55
AVG Volume (30 Days)
744.9K
1.5M
Earning Date
05-04-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
69.12
EPS
N/A
0.02
Revenue
N/A
$726,437,000.00
Revenue This Year
$8.44
$18.80
Revenue Next Year
$12.34
$11.70
P/E Ratio
$24.08
$1,029.50
Revenue Growth
N/A
40.45
52 Week Low
$38.24
$19.69
52 Week High
$93.13
$28.35

Technical Indicators

Market Signals
Indicator
TDW
ACAD
Relative Strength Index (RSI) 54.95 39.08
Support Level $80.29 $20.06
Resistance Level $88.99 $22.64
Average True Range (ATR) 3.23 0.78
MACD 0.01 -0.18
Stochastic Oscillator 73.41 10.83

Price Performance

Historical Comparison
TDW
ACAD

About TDW Tidewater Inc.

Tidewater Inc provides marine and transportation services to the offshore energy industry. The company's vessels and associated services support all phases of offshore crude oil and natural gas (also referred to as oil and gas) exploration activities, field development, production, and maintenance, as well as windfarm development and maintenance. Its services include towing and anchor handling for mobile offshore drilling units; transporting supplies and personnel necessary to sustain drilling, workovers, production activities, field abandonment, dismantlement, and restoration activities; and Others. The group manages its business through five segments, including the Americas, Asia Pacific, Middle East, Europe/Mediterranean, and West Africa.

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise to makes a difference for underserved neurological and rare disease communities around the world. It has two core franchises in neurological and rare diseases. Its neurological disease is anchored by the commercial product NUPLAZID (pimavanserin), which is the first and only drug approved by the U.S. (FDA) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PDP). Its rare disease is anchored by the commercial product DAYBUE, which is the first and only drug approved for the treatment of Rett syndrome. Its clinical-stage development efforts are focused on Alzheimer's disease psychosis, Lewy Body Dementia psychosis, and multiple other programs.

Share on Social Networks: